VILOTOS
Live / Registered — Registered (as of 08 Mar 2022)
What this means for you
Registered since 08 Mar 2022. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 08 Mar 2028: the §8 declaration of use).
Record
- Serial number
- 88955893
- Registration number
- 6667556
- Mark type
- Word mark
- Filed
- 09 Jun 2020
- Published for opposition
- 27 Oct 2020
- Registered
- 08 Mar 2022
- Next maintenance filing
- §8 declaration of use, due by 08 Mar 2028 (grace period to 08 Sept 2028)
Goods and services
- Class 042 — Scientific and technological services: MEDICAL AND SCIENTIFIC RESEARCH IN THE FIELD OF PHARMACEUTICALS AND CLINICAL TRIALS
Owner
- Vilotos Pharmaceuticals, Inc., Baltimore, MD, US
- Vilotos Pharmaceuticals, Inc., Baltimore, MD, US
- Vilotos Pharmaceuticals, Inc., Baltimore, MD, US
Prosecution history
- 12 Jan 2023 — WITHDRAWAL OF ATTORNEY GRANTED
- 12 Jan 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED
- 08 Mar 2022 — REGISTERED-PRINCIPAL REGISTER
- 01 Feb 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 31 Jan 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Jan 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Dec 2021 — USE AMENDMENT FILED
- 12 Jan 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Dec 2021 — TEAS STATEMENT OF USE RECEIVED
- 24 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Jun 2021 — SOU EXTENSION 1 GRANTED
- 22 Jun 2021 — SOU EXTENSION 1 FILED
- 22 Jun 2021 — SOU TEAS EXTENSION RECEIVED
- 22 Dec 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Oct 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED